The risk of heart-specific death in breast cancer patients

Yunbo Luo1,2, Long Zhao3, Peng Qu4,5,6

  • 1Department of Breast Surgery, Plastic Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, P.R. China.

Scientific Reports
|August 2, 2025
PubMed

Insights

Breast cancer survivors face a higher risk of heart-specific death (HSD) compared to the general population. Factors like race, age, and tumor stage influence this risk, necessitating targeted medical interventions.

Area of Science:

  • Oncology
  • Cardiology
  • Epidemiology

Background:

  • Improving breast cancer (BC) treatments leads to increased survival.
  • Survivors are increasingly dying from non-cancer conditions, notably heart disease (HD).

Purpose of the Study:

  • To analyze the risk of heart-specific death (HSD) in breast cancer patients.
  • To identify demographic and clinicopathological risk factors for HSD in this population.

Main Methods:

  • Utilized the Surveillance, Epidemiology, and End Results (SEER) database (2000-2019).
  • Calculated Standard Mortality Ratios (SMR) for HSD.
  • Employed Cox Proportional hazard models to determine risk factors and 95% Confidence Intervals (CI).

Main Results:

  • Included 655,552 breast cancer patients; 149,708 (22.8%) died.
  • Heart disease caused 15.2% of deaths, becoming the leading cause after 10 years.
  • The SMR for HD was 8.14, indicating significantly higher risk in BC patients.
  • Race, age, marital status, income, grade, stage, and subtype were independent risk factors for HSD.

Conclusions:

  • Breast cancer patients have a substantially elevated risk of heart-specific death.
  • Demographic characteristics and tumor factors significantly influence HSD risk.
  • Medical strategies are crucial to mitigate heart disease risk in breast cancer survivors.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
55
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
38
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
34
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.1K